Select Page

News

Highest global enroller for brain tumour clinical trial

Highest global enroller for brain tumour clinical trialDr. Petrecca and his team (Josephine Chu and Adrien Poulin) have received a 2018 Scimega Network Champion Award for their outstanding performance as the highest global enroller for their U.S. Biotech Sponsor’s...

CTV with Dr. Paul Giacomini on MS in Canada

Your Morning with Dr. Paul Giacomini Canada has one of the highest rates of MS in the world. Join Dr Giacomini on CTV's "Your Morning" as he talks about why MS rates are so high in Canada and what is being done to fight it.

Dr. Angela Genge, recipient of the Forbes Norris Award

Dr. Genge awarded the 2018 Forbes Norris Award A big congratulations to our inspiring director, Dr. Angela Genge, on receiving the Forbes Norris award at the ALS MND symposium in Glasgow, Scotland! She is recognized for her exceptional care and compassion towards ALS...

The first on the INTRAGO brain tumour trial in Canada

The first on the INTRAGO brain tumour trial in Canada Le premier de l'essai INTRAGO sur les tumeurs cérébrales au Canada Glioblastoma Multiforme is grade IV brain cancer that is very aggressive. There are currently no cure but research is advancing to find new ways to...

Eastern Neuromuscular Course Review

Eastern Neuromuscular Course Review (From https://www.mcgill.ca/neuro/events/eastern-neuromuscular-course-review) Dr. Nic Dupré of Laval University, Dr. Angela Genge of The Neuro and the members of our organizing committee are pleased to announce that...

Health Canada approves new drug to treat patients ALS

Health Canada approves new drug to treat patients with Amyotrophic Lateral Sclerosis (ALS) From CBC News: Ottawa has approved a drug to slow the progression of ALS. Edaravone is the first promising ALS drug to be approved in Canada in nearly 20...

Dr. Angela Genge – Neuro XXceptional

Dr. Angela Genge - Neuro XXceptional Neurologist Dr. Angela Genge is the Director of the ALS Clinic and the Clinical Research Unit at The Neuro. Dr. Genge has been awarded the YWCA Woman of Distinction Award in Science and Technology for her...

CJAD with Dr. Simon Ducharme

CJAD with Dr. Simon Ducharme Dr. Ducharme, a neuropsychiatrist at the Neuro was on CJAD to comment on clinical trials in dementia and Alzheimer’s. “Alzheimer’s is a complicated disease. Amyloid is one of the targets…We might need to treat on more than one...

Dr. Genge on CJAD Andrew Carter

For #ALSAwareness Month, Dr. Genge was on CJAD radio to discuss clinical trials and the need for new therapies in ALS. The month may be almost over, but the fight never ends for patients and their families.

Recent Facebook Posts

(Fr suivant) May is MS Awareness Month. Did you know Canada has some of the highest rates of MS in the world? Canadians living with MS experience the disease differently. #MSAwarenessMonth

**Learn more about current #clinicaltrials in MS by visiting our website cru.mcgill.ca **

//

Mai est le mois de sensibilisation à la SEP. Saviez-vous que le Canada a l'un des taux de SEP les plus élevés au monde? Les Canadiens atteints de SEP éprouvent la maladie différemment. #MoisdeSensibilisationSEP

** Pour en savoir plus sur les #essaiscliniques actuels dans la SEP, visitez notre site Web cru.mcgill.ca **
... See MoreSee Less

View on Facebook